Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NemaLife operates a high-throughput in vivo screening platform using C. elegans, microfluidics, and AI to discover and characterize bioactive ingredients, probiotics/postbiotics, and drug candidates for aging-related, neurological, and metabolic indications. Its work is primarily preclinical, supported by multiple NIH SBIR Phase I awards and partner-enabled clinical trials for ingredients but it does not itself run human therapeutic trials.[2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NemaLife.